Guide

Gummy Supplement Contract Manufacturer Selection: aw, Pectin vs Gelatin, Potency Holding and the Audit Pack

Gummies are the highest-CPC, highest-margin, highest-failure-risk dose form in dietary supplements. The chemistry is unforgiving — water activity drifts above 0.65 and the product blooms or microbially fails; a labile active (Vit C, B12, melatonin, methylated folate) decays past label claim before end-of-shelf-life; a pectin base behaves nothing like gelatin under heat-hold and bloom. Choosing the wrong CMO turns a hero SKU into a recall. This guide is the buyer's selection framework: the chemistry decisions, the line capability questions, the potency-holding evidence to demand, and the 21 CFR 111 + NSF 173 audit overlay that separates a competent gummy CMO from a contract sweet manufacturer pretending to make supplements.

Start free trial Free trial, no credit card, onboard in days, not months.

Pectin vs gelatin — the binary decision that drives everything downstream

Gelatin (bovine or porcine, Type A acid-cured or Type B alkali-cured, 150–300 Bloom) gives the classic chewy gummy texture, sets at refrigeration, melts in the mouth, and works in a depositor line at 70–80°C. Pectin (HM high-methoxyl or LM low-methoxyl amidated) gives a shorter, less chewy texture, sets by acid + sugar (HM) or calcium (LM), runs at 95–105°C deposit, and is the only credible choice for vegan, Halal-/Kosher-pareve and many religious-market gummies. The choice cascades: pectin needs tighter pH control (3.0–3.6), higher cook temperatures (a problem for thermally labile actives), and longer cure times in conditioned room (24–72 h at 25°C/40% RH) — gelatin is more forgiving on actives but blocks the entire vegan/religious market. Ask the CMO which they recommend before showing them the formulation, then ask why.

Water activity (aw) — the shelf-life parameter that actually governs gummies

Gummy shelf life is governed by water activity, not total moisture. Target aw 0.50–0.60: stable against yeast/mould (USP <2023> non-aqueous oral solid limits hold) and against sugar bloom from re-crystallisation. aw drifts up from the depositor through the cure room to the bag — every 0.05 increase shortens microbial-safe shelf life by ~30%. Demand the CMO's aw control protocol: in-process aw at deposit, post-cure aw, finished-pack aw at QC release, and stability aw at 25°C/60% RH and 30°C/75% RH. A CMO that cannot show you the aw trend across 6 months of one SKU is making confectionery, not a supplement. AOAC 978.18 / ISO 21807 are the reference methods.

Potency holding — the overage decision and the assay evidence

Every labile active in a gummy needs an overage to ensure the analytical value at end of shelf life still meets the Supplement Facts label claim (21 CFR 101.9(g) allows the +20% reasonable excess). Typical real-world overages: Vit C 30–50%, B12 50–100%, methylfolate 30–50%, melatonin 5–10%, D3 15–25%, iron 0% (stable) — but the right number is the CMO's stability data on YOUR pack and YOUR base, not an industry rule of thumb. Demand the stability-indicating HPLC method (ICH Q2(R2)), the forced-degradation study showing degradant resolution, and 12-month real-time data at 25°C/60% RH on the proposed base. A CMO that quotes overage without per-active stability data is gambling with your label claim and your recall budget.

Line capability — depositor vs starch mogul, throughput, dose accuracy

Two line types dominate. (1) Starch mogul: trays of food-grade starch are printed with mould cavities, slurry is deposited, gummies cure in the starch, are de-moulded, polished and packed. High throughput (500+ kg/h), low changeover, but starch carryover is an allergen risk if you also run a wheat-starch line. (2) Silicone-mould depositor: cavity moulds are heated, slurry deposited, cooled, de-moulded. Lower throughput (50–200 kg/h), tighter dose accuracy (±3% achievable vs ±5–7% on starch mogul), no starch carryover risk. Ask the CMO: which line will my SKU run on, what is the validated dose-CV per cavity per shift, and what is the cleaning validation between SKUs on that line.

The 21 CFR 111 + NSF 173 / USP <2750> overlay on a gummy CMO

Gummies are 21 CFR 111 dietary supplements — every Subpart applies. The gummy-specific 483 hot zones: (a) Subpart E component identity — the active is often a powder shipped to a confectionery CMO that has never done identity-by-HPTLC or FTIR; demand 111.75 evidence with method validation for the matrix, (b) Subpart D cleaning validation — colour and flavour carryover is visible to consumers but allergen and active carryover is invisible until it is recalled; demand HBEL-derived MACO with TOC swab evidence, (c) Subpart K lab operations — gummies require microbial USP <2021>/<2022>, heavy metals USP <2232>, and aw; demand the QC method panel. NSF/ANSI 455-2 and USP <2750> add tiered supplier qualification and finished-product third-party testing — both retailer-mandatory for Amazon, Costco, Whole Foods placement.

The walk-away red flags specific to gummy CMOs

(1) Confectionery-only history with no 21 CFR 111 cGMP record — confectionery FDA registration is not the same regulation. (2) No aw control programme. (3) No stability-indicating HPLC for the labile actives in the active list — potency-only assays cannot defend a stability claim. (4) Cleaning validation does not cover the colour/flavour/allergen carryover between SKUs you intend to run. (5) Sugar-based only, no sugar-reduced or allitol/isomalt options if your brand needs them. (6) No on-site microbial lab — sending out USP <2021> samples adds 5–7 days to release. (7) Single-source pectin or gelatin supplier with no qualified back-up. (8) No NSF 173 / USP <2750> certificate, or scope excludes gummies. (9) Cure room without temperature-and-humidity mapping. (10) No documented overage rationale per active, only an industry default.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

Water activity (aw) for low-moisture supplements

Water activity (aw), the ratio of vapour pressure of water in the product to that of pure water, is the moisture parameter that actually governs microbial growth — not total moisture. aw <0.60 inhibits all microbial growth; <0.70 stops most yeasts/moulds; <0.85 stops Salmonell...

Vitamin overage (label-claim overage)

Vitamin overage is the deliberate excess of a labile nutrient (Vit A, B1, B12, folate, D3) added at compounding so that after process loss and end-of-shelf-life decay the analytical value still meets the Supplement Facts label claim under 21 CFR 101.9(g) (within +20% reasonabl...

Forced degradation & stability-indicating methods

Forced degradation per ICH Q1A(R2) stresses the active under acid, base, oxidation (H₂O₂), thermal, humidity and photolytic (ICH Q1B Option 1 or 2) conditions to generate degradants. A stability-indicating method is then validated under ICH Q2(R2) to resolve and quantify those...

Weight variation USP <2091>

USP <2091> weight variation, the supplement-specific complement to drug-product Uniformity of Dosage Units <905>, requires that the average weight of 10 dosage units fall within ±10% (single-component supplements) or ±15% (multi-component) of the labelled weight, with no indiv...

Supplier qualification audit (supplements)

Supplier qualification under 21 CFR 111.75(a)(2) and NSF/ANSI 455-2 requires an initial on-site or documented audit, a quality agreement, a risk classification (Tier 1 active/botanical, Tier 2 functional excipient, Tier 3 commodity), and a re-qualification cycle (typically Tie...

Annual Product Review (supplements)

An Annual Product Review (APR) — adapted from 21 CFR 211.180(e) but a best-practice expectation for any commercially mature dietary supplement SKU — is the once-a-year statistical review of every batch produced, covering yields, OOS/OOT events, complaints, deviations, change c...

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Modules that do the work

Gummy-specific cGMP spine

aw, cleaning, identity and stability on one record.

Stability and overage evidence under control

Per-active overage tied to the supporting decay data.

Pectin / gelatin supplier qualification

Tier-1 botanical and base-supplier audit cadence.

Industries this hits hardest

Dietary supplements

Frequently asked

Are pectin gummies more expensive to manufacture than gelatin?

Yes — typically 15–25% higher cost per kg at parity throughput. Pectin needs tighter pH control, higher cook temperatures, longer cure times, and the pectin itself costs more per kg than gelatin. The cost is recovered if vegan / Halal-pareve / Kosher-pareve positioning lets you sell at a premium SKU price; if it does not, gelatin is the right base.

Why do my gummies fail stability at 6 months when the 3-month data was fine?

Almost always one of three: (1) water activity drift above 0.60 in the pack — the gummy absorbs moisture from the headspace, microbial limits fail; (2) a labile active is decaying faster than your overage covers — the stability-indicating method shows the degradant growing; (3) sugar bloom from re-crystallisation when stored above 25°C. All three are predicted by the right pre-launch chemistry — they are CMO-selection problems, not surprise failures.

Can a US-based gummy CMO ship to the UK without re-formulation?

Often no. UK rules under the Food Supplements (England) Regulations 2003 and FIR 1169/2011 require the prescribed UK label format and a UK/EU responsible person; some US-permitted sweeteners, colours and titanium dioxide (banned as a food additive in the EU/GB since 2022) are not permitted in UK gummies. Plan for at least a label re-format and a colour swap before UK launch.

What dose accuracy can I expect on a gummy line?

Validated dose CV ±3% on a silicone-mould depositor with cavity-level temperature control; ±5–7% on a starch-mogul line. Both are well within the 21 CFR 111 weight-variation expectation under USP <2091>, but a tight-dose active (methylated folate at 400 µg, melatonin at 0.3 mg) needs the depositor line. Ask the CMO for the per-cavity CV from the last PPQ batch.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →